Previous research has demonstrated the utility of NKAIN1 mRNA expression in urine sediment for early clinical diagnosis and in cancer tissue for immunotherapy in prostate cancer patients24,25. This evidence concerns the gene NKAIN1 and Familial prostate cancer.